OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Digitalization can improve workflow and output but maintaining data integrity is a concern.
A best practices approach to pharma’s most challenging-to-inspect container.
Alternatives to traditional freeze-drying may reshape biological development and the cold chain.
June 11, 2021
The CGT Catapult has formed a consortium aimed at advancing the technology development and lowering costs of cell and gene therapy manufacturing.
June 08, 2021
The vaccine is now authorized for ages 12 and older in European Union member states and the UK.
VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.
AGC Biologics has partnered with BioNTech to further supply plasmid DNA starting material from its Heidelberg, Germany, facility for the Pfizer-BioNTech COVID-19 vaccine.
June 07, 2021
FDA has granted accelerated approval to Biogen for Aduhelm (aducanumab), a new mAb treatment for Alzheimer’ disease.
The Module Type Package standard is now supported in Emerson’s DCS and PLCs.
June 02, 2021
Currently, PNI offers a Genetic Medicine Toolkit, including its GenVoy LNP delivery platform and NanoAssemblr microfluidic-based nanoparticle manufacturing platform, for the development of genetic medicines.
The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.
Controlling certain atmospheric conditions in a closed NGI processing chamber can reduce bioburden without disinfectants.
Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.